Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Factbox-Stocks to watch as Biden and Trump vie for presidency

Published 07/03/2024, 07:49 AM
Updated 07/03/2024, 07:51 AM
© Reuters. FILE PHOTO: Democratic Party presidential candidate U.S. President Joe Biden and Republican presidential candidate former U.S. President Donald Trump speak during a presidential debate in Atlanta, Georgia, U.S., June 27, 2024 in a combination photo. REUTE

(Reuters) - The first U.S. presidential debate saw President Joe Biden turning in a fitful performance, especially at the beginning, as he exchanged barbs with former President Trump on abortion, immigration, the wars in Ukraine and Gaza and even their golf games.

Both candidates defended their handling of the economy ahead of the Nov. 5 election rematch, which opinion polls show has virtually been a tied race for months.

Here is a look at the stocks that are likely to be impacted and how, depending on who comes to power:

FINANCIALS

UBS accounts for the prospect of less stringent capital and liquidity rules and easing financial regulation under a second Trump administration.

The brokerage sees benefits for big banks like JPMorgan & Chase, Bank of America, Wells Fargo and smaller lenders including Discover Financial, KeyCorp (NYSE:KEY) and Synchrony Financial (NYSE:SYF).

SOLAR STOCKS

J.P.Morgan analysts believe opposition to the green revolution by Trump and other Republicans could pose a risk to investments in clean energy manufacturing, facilitated by the tax incentives in the Inflation Reduction Act of 2022.

UBS sees a second Biden government keeping those incentives intact for solar manufacturers such as First Solar (NASDAQ:FSLR), NextEra Energy (NYSE:NEE) and Sunrun (NASDAQ:RUN).

CLEAN ENERGY AND OIL COMPANIES

Continued support for electrification and blue and green hydrogen production under a Biden administration could boost stocks such as Eaton (NYSE:ETN), Quanta Services (NYSE:PWR), Tesla (NASDAQ:TSLA) and Air Products and Chemicals (NYSE:APD), according to UBS.

Existing incentives from the present government would continue driving advantages for energy-efficient product manufacturers such as Johnson Controls (NYSE:JCI) and Trane Technologies (NYSE:TT), as well as waste management companies with recycling infrastructure such as Waste Management (NYSE:WM) and Republic Services (NYSE:RSG).

However, increased oil and natural gas investment, more drilling activity and higher natural gas exports could benefit producers such as Exxon Mobil (NYSE:XOM), Cheniere Energy (NYSE:LNG) and ConocoPhillips (NYSE:COP) under Trump 2.0.

TARIFFS

A second Trump administration is expected to be much more protectionist in terms of import tariffs. "The consumer discretionary sector is exposed in that environment," UBS analysts say.

As president, Trump started a tariff war with China and has floated tariffs of 60% or higher on all Chinese goods and a 10% or higher universal tariff on all imports, a move he says will eliminate the trade deficit.

U.S. tariffs on Chinese imports could help domestic manufacturers, namely legacy carmakers Ford (NYSE:F) and General Motors (NYSE:GM) and steel producers such as Nucor (NYSE:NUE) and Steel Dynamics (NASDAQ:STLD), UBS analysts say.

TRUMP-RELATED STOCKS

Investors expect stocks related to Donald Trump to move in tandem with the chances of his winning the presidency. These include Trump Media & Technology, in which the former president owns a majority stake, software firm Phunware and video-sharing platform Rumble.

PRISON OPERATORS

U.S. prison operators like Geo Group (NYSE:GEO) and CoreCivic (NYSE:CXW) are potential beneficiaries of a second Trump administration, on promises of a crackdown on illegal immigration and restrictions on legal immigration by the Republican candidate, which could boost demand for detention centers.

PHARMACEUTICALS AND INSURERS

UBS sees a lower risk of drug price cuts and an inclination towards Medicare Advantage in a Republican-dominated government, which could help drugmakers Eli Lilly and Company (NYSE:LLY) and Merck, as well as health insurers such as Humana (NYSE:HUM) and UnitedHealth (NYSE:UNH).

M&A-RELATED BENEFICIARIES

A second Trump administration would likely take a more lenient approach to antitrust regulation enforcement in the world's biggest economy, according to J.P.Morgan analysts.

UBS expects banks such as Goldman Sachs, Morgan Stanley, Lazard (NYSE:LAZ) and Evercore, which benefit from M&A activities, to gain from such a policy change.

SEMICONDUCTOR MANUFACTURING

Given the fierce competition with China on semiconductor chips, UBS expects a second Trump government to drive support for domestic semiconductor manufacturing companies such as Applied Materials (NASDAQ:AMAT), KLA Corp, Intel (NASDAQ:INTC) and Texas Instruments (NASDAQ:TXN).

© Reuters. FILE PHOTO: Democratic Party presidential candidate U.S. President Joe Biden and Republican presidential candidate former U.S. President Donald Trump speak during a presidential debate in Atlanta, Georgia, U.S., June 27, 2024 in a combination photo. REUTERS/Brian Snyder/File Photo

AGRICULTURAL SUPPORT

As more tariffs on Chinese imports are proposed under Trump 2.0, more federal assistance could be provided to farmers for lost exports amid the trade war. These initiatives could help agricultural product manufacturers and suppliers such as Deere (NYSE:DE) and Co and Tractor Supply Company (NASDAQ:TSCO), analysts at UBS say.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.